Mb (myoglobin) is a haemoprotein present in cardiac, skeletal and smooth muscle and is primarily responsible for the storage and 'facilitated transfer' of molecular oxygen from the cell membrane to mitochondria. Also, Mb plays a role in regulating ᭹ NO (nitric oxide) homoeostasis through (i) binding increased the concentration of Mb within cultured rat or primary human VSMCs as judged by Western blot analysis and indirect immunofluorescence microscopy. Cell viability did not decrease in these cells at the ᭹ NO doses tested. Importantly, sub-culturing isolated rat aortic segments for 7 days in the presence of L-arginine at 37
INTRODUCTION

Vascular endothelium-derived
᭹ NO (nitric oxide) plays a vital role in vessel dilation [1, 2] by regulating peripheral vascular resistance and ultimately circulating blood pressure. To elicit vessel dilation, ᭹ NO binds to, and activates, sGC (soluble guanylyl cyclase) within vascular smooth muscle, which in turn catalyses the conversion of guanosine-5 -(3-thiotriphosphate) into cGMP [3] . Synthesized cGMP activates a cascade of effector proteins that initiate vessel dilation.
However, ᭹ NO is generally considered to be a highly reactive molecule. Within the vascular lumen, millimolar concentrations of circulating oxygenated haemoglobin are primarily responsible for reactions with ᭹ NO [4, 5] . Within cardiac, skeletal and smooth muscle [6, 7] , Mb (myoglobin) potentially plays a greater role in regulating the tissue content of ᭹ NO [8, 9] . Thus oxygenated Mb rapidly oxidizes ᭹ NO (k ∼ 10 −4 -10 −5 M −1 · s −1 ) to yield higher order nitrogen oxides [10] ; ferrous and ferric Mb yield a stable haem-NO complex (Mb-NO) (dissociation constant K d ∼ 10 −5 M) [11] and Mb from at least some different species [12, 13] contain a free cysteine residue that can be nitrosylated to yield S-nitroso-Mb, which is a store of vasoactive ᭹ NO capable of eliciting vascular relaxation. In strong support for the idea that Mb plays a critical role in controlling physiological ᭹ NO, oxyMb is demonstrated to decrease the concentration of ᭹ NO in cardiac myocytes [14] . Regulation of myocardial ᭹ NO is crucial for maintaining coronary blood flow, cardiac contractility and normal heart function.
In the present study, we investigated the relationship between pathological concentrations of vascular ᭹ NO and the response to Mb within VSMCs (vascular smooth muscle cells). Our data demonstrate that ᭹ NO stimulates a increase in Mb gene and protein expression in VSMCs through a feedback regulatory mechanism. The physiological implication of this mechanism is discussed in relationship to Mb's ability to modulate ᭹ NO concentrations within the vessel wall, particularly with reference to pathologies that may elicit uncontrolled production of the potent vasodilator.
EXPERIMENTAL
Materials
Sodium nitrite, trypsin, fetal bovine serum, L-glutamine, penicillin, streptomycin, copper(II)sulfate, acrylamide, ammonium persulfate, SDS, ABTS [2,2 -azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)] and spermineNONOate (N- [2-aminoethyl] -N-[2-hydroxy-3-nitroso-hydrazine]-1,2-ethelenediamine) were obtained from Sigma. DeaNO (diethylamineNONOate) was obtained from Cayman Chemicals. The ᭹ NO trap DAF-FM (4-amino-5-methylamino-2 7 -difluorofluorescein diacetate) was from Molecular Probes. All solvents and chemicals employed were of the highest quality available.
Primary RASMCs (rat aortic VSMCs) (Cell Applications) and human VSMCs (A.T.C.C.) were cultured in Dulbecco's modified Eagle's medium/Ham's F12 (Sigma) containing 10 % serum, 100 units/ml penicillin and 100 μg/ml streptomycin, at 37
• C in a humidified atmosphere of 5 % CO 2 . All VSMCs were cultured to 80-90 % confluence and used between passages 8-12. Prior to use, VSMCs were washed in HPSS (Hepes-buffered physiological salt solution, pH 7.4) [15] containing 22 mM Hepes, 124 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 0.16 mM HPO 4 , 0.4 mM H 2 PO 4 , 5 mM NaHCO 3 and 5.6 mM D-glucose. Where required, the cell protein concentration was determined using a commercial kit (bicinchoninic acid assay, Sigma) and the values were used to normalize all biochemical parameters to account for potential variability in cell density.
᭹ NO treatment of VSMCs
The ᭹ NO donors DeaNO and spermineNONOate were prepared in 0.1 M NaOH and diluted in HPSS immediately before use. Cultured VSMCs were washed twice in HPSS and treated with the ᭹ NO-donor as indicated in the legends to the Figures. In the case for DeaNO, the ᭹ NO-donor was administered to yield cumulative concentrations of ᭹ NO (final concentration 100 nM, 1 or 10 μM). These doses of DeaNO corresponded to rates of ᭹ NO release of 0.6, 6 or 60 nM · s −1 respectively, as determined from the half-life (t 1/2 ) = 2 min at 37
• C indicated by the manufacturer. In the case for spermineNONOate, a final ᭹ NO concentration of 100 nM (corresponding to a rate of ᭹ NO release of 0.21 nM · s −1 ; t 1/2 = 39 min at 37
• C) was employed. These two ᭹ NO-donors were selected on the basis of different rates of decomposition to release ᭹ NO, thereby mimicking the exposure of VSMCs to rapid or prolonged exposure to ᭹ NO. After ᭹ NO treatment, cells were re-cultured in complete media for a further 2, 5 or 24 h. To assess whether ᭹ NO entered the cultured VSMCs, experiments were performed with cells pre-loaded with DAF-FM (Sigma). After 1 h exposure to ᭹ NO, cells were imaged with an inverted fluorescence microscope (Zeiss Axiovert 200) fitted with a 60× objective. Images were captured with an MRC 200 digital camera (Zeiss).
Gene regulation in cultured VSMCs
First strand cDNA synthesis Cultured VSMCs were harvested and total RNA was extracted with a commercial kit (Sigma). First-strand cDNA was generated via reverse transcriptase by Oligo(dT) priming (Bioline, Sydney, Australia) as described previously [16] .
RT-PCR (reverse transcription-PCR)
Primers specific for rMb (rat Mb), MNF (myocyte nuclear factor), iNOS (inducible nitric oxide synthase) and the house-keeping genes GAPDH (glyceraldehyde phosphate dehydrogenase), β-actin and ribosomal S29 RNA, were synthesized by Proligo (Lismore, NSW, Australia). Primer sequences for rMb were 5 -CCTGGGTACCATCCTGAAGA-3 and 5 -GAGCATCTGCT-CCAAAGTCC-3 ; for MNF, 5 -CTACCCCAACAATGCACCTT-3 and 5 -GAGGACTTGCTGGACAGGAG-3 ; for iNOS,  5 -CACCTTGGAGTTCACCCAGT-3 and 5 -ACCACTCGTA-CTTGGGATGC-3 ; GAPDH, 5 -ACCACAGTCCATGCCAT-CAC-3 and 5 -TCCACCACCCTGTTGCTGTA-3 ; for β-actin,  5 -AGCCATGTACGTAGCCAT-CC-3 and 5 -CTCTCAGCTGT-GGTGGT-GAA-3 and for ribosomal S29 RNA, 5 -GGGT-CACCAGCAGCTGTACT-3 and 5 -CCGATATCCTTCGCGTA-CTG-3 . The annealing temperature for all primers used here was  60 • C. The contents of reaction mixtures and conditions employed were as described in detail elsewhere [16] . PCR products were resolved on 1 % (w/v) agarose gels containing 2 μl ethidium bromide, and visualized under short-wavelength UV light. Densitometric analysis was carried out using a BioDocAnalyse system (Biometra, Gottingen, Germany). For assessing iNOS gene regulation in aortic tissues, real-time (quantitative) PCR was used with a ICycler (Bio-Rad) as described in detail previously [17] . Finally, all gene regulation was expressed as a fold-change relative to the corresponding vehicle-treated control.
Western blotting
Cell lysates, from ᭹ NO-treated VSMCs or aortic homogenates (see below), were centrifuged (13 000 g, 10 min) and the supernatant subjected to immunoprecipitation with GammaBind G Sepharose (Amersham Biosciences, Uppsala, Sweden). Isolated beads were boiled and the supernatant was subjected to SDS/PAGE, transferred on to a nitrocellulose membrane and Mb bands visualized with a human Mb monoclonal antibody (1:1000 v/v, Sigma, Australia) and enhanced chemiluminescence detection (Amersham Biosciences). Densitometric analysis of Western blots was carried out using a BioDocAnalyze system (Biometra, Gottingen, Germany) with normalizing against viable cell number or total homogenate protein prior to between treatment comparisons.
Immunofluorescence studies
For the in situ visualization of cellular Mb, human VSMCs were grown on to coverslips, washed and overlayed with HPSS containing 10 μM DeaNO or vehicle alone (control) and treated as described above. After incubation, cells were fixed in 4 % (w/v) paraformaldehyde, permeablized with 0.1 % (v/v) saponin, and non-specific binding was blocked with 1 % (w/v) BSA in PBS (pH 7.4), before being probed for Mb using a polyclonal anti-human Mb antibody (Sigma; final dilution 1:250, v/v) and a secondary anti-rabbit IgG-FITC conjugate (Amersham; final dilution 1:1000, v/v). Fluorescent images (excitation: 488; emission: 525 nm) were captured using an Olympus Fluoview FV500 confocal microscope (Olympus) fitted with a 100× objective.
Assessing holo-Mb within VSMCs
Apomyoglobin is able to bind a haem prosthetic group in a non-covalent fashion to yield holo-Mb. To determine whether exposure of VSMCs to ᭹ NO resulted in the formation of holo-Mb or the Mb apoprotein that is deficient in haem, we purified cell lysates to isolate fractions containing Mb by liquid chromatography as described previously [18] . Briefly, isolated cell pellets were treated with phosphate buffer (50 mM, pH 7.4) containing 1 % (v/v) Triton X-100, protease inhibitor cocktail (Roche), 1 mM EDTA and 10 μM butylated hydroxytoluene. The metal chelator and low-molecular-mass antioxidant were added to inhibit post-translational oxidative modification to cell proteins including Mb. Next, the protein content of the lysate was determined and samples containing 25 pg of total protein were injected on to a C 4 column (25 cm, diameter 4 mm, particle size 5 μm) and cell proteins were separated using a linear gradient over 35 min starting at 100 % solvent A [0.1 % TFA (trifluoroacetic acid) in water] and ending at 100 % solvent B (0.09 % TFA in 65 % aqueous acetonitrile) with monitoring at 210 nm. Samples of authentic horse heart Mb (Sigma) were employed to identify the retention time for Mb. Importantly, the column was maintained at 18
• C using a column oven. Under these conditions, Mb eluted between 19-21 min with a majority present as the holo-protein [18] . Note, at higher temperatures, the protein unfolds and haem is displaced from the apoprotein [18] .
Next, we employed Mb-mediated oxidation of ABTS as an independent assessment of whether holo-Mb protein eluted from the VSMC lysates. Thus Mb-containing fractions, isolated from the lysates of cultured VSMCs exposed to ᭹ NO by liquid chromatography as described above, were employed in peroxidase activity assays. Pooled samples were resuspended in 50 mM phosphate buffer, pH 7.4, supplemented with 1 mM ABTS. Next, the samples were treated with 100 μM H 2 O 2 and the rate of ABTS oxidation was monitored at 420 nm using a Hitachi UV-Vis spectrophotometer (over 30 min) as a surrogate for Mb peroxidase activity [19] . In some experiments, the pooled Mb-containing fractions were pre-treated with 50 μM sodium cyanide (Sigma) prior to use in ABTS oxidation studies. Cyanide is a ligand for haem in Mb and binds strongly to the iron centre and inhibits peroxidase activity of the protein.
Measurement of VSMC viability
The membrane integrity of VSMCs was assessed by Trypan Blue exclusion [20] . The extent of apoptotic and necrotic cell death was determined by dual-staining with FITC-annexin V (FITC-conjugated annexin V), with PI (propidium iodide) counterstaining as previously described in [16] .
Measurement of ᭹ NO
The accumulation of ᭹ NO in the media bathing the aortic segments was monitored by a ᭹ NO-selective electrode (ISO-NO MII) coupled with a DUO-18 TM data recorder (World Precision Instruments, v1.55) as described previously [21] . Media samples were treated with a mixture of nitrate reductase and NADPH to quantitatively reduce nitrate to nitrite, which was then chemically reduced to regenerate ᭹ NO for monitoring with the ᭹ NO-selective electrode as described previously [22] . The area under the peak response curve was estimated using integration software supplied with the system and the ᭹ NO concentration determined by comparison with a standard curve [13] . Finally, evolved ᭹ NO was normalized to total homogenate protein prepared from the corresponding pooled aortic segments (see below). In the absence of tissue, the levels of ᭹ NO, derived from nitrite in the media, were <2 pmol/mg of protein. All values of ᭹ NO determined in the samples of media that bathed the isolated rat aortic segments were corrected for this basal level of ᭹ NO/nitrite.
Animals
All animal work was performed with approval from the Sydney South West Area Health Services Animal Ethics Committee (approval number 2006-008A). All studies were performed by a team of experienced researchers that strictly adhered to the appropriate local ethical procedures for the handling of animals for experimental procedures. Male Sprague-Dawley rats (0.4-0.6 kg) were obtained from the ARC facility (Western Australia) and housed in pairs for the entire study period. Initially, rats were acclimatized to the local environment (1 week minimum). Standard rodent chow and water were provided ad libitum for 6-8 weeks prior to the harvest of the entire aorta for biochemical studies. Prior to harvest of aorta, animals were administered with isofluorane using a metered anaesthetic machine with medical grade oxygen as the carrier gas (2 % v/v in oxygen, 1.5 l/min). Next, the unconscious animals were injected i.p.
(intraperitoneally) with ketamine (50 mg/kg of weight) and xylazine (10 mg/kg of weight). After 5 min, animals were tested for reflex action and if judged sufficiently anaesthetized, blood was harvested by direct cardiac puncture and finally the aorta was isolated following a thoracotomy procedure. Animals did not recover from this procedure. When required, the descending aorta was cut into 5 mm sections and carefully cleaned of extravascular tissue. Segments were then pooled in groups of 10 and immersed in complete media and incubated at 37
• C in a humidified atmosphere of 5 % CO 2 . To test whether ᭹ NO stimulated Mb gene and protein expression in vascular tissues, pooled aortic rings were incubated in complete media containing 100 μM L-arginine for periods of up to 7 days. Following incubation, aortic sections and media were harvested after 0, 1, 3, 5 and 7 days of incubation and frozen immediately and stored at − 80
• C.
Preparation of aortic homogenates
Where required, frozen samples of aortic rings were thawed, placed into 2 ml of phosphate buffer (50 mM, pH 7.4) containing 1 % (v/v) Triton X-100, protease inhibitor cocktail (Roche), 1 mM EDTA and 10 μM butylated hydroxytoluene and then homogenized with a rotating piston and matching teflon-lined tube as described in [23, 24] . The total homogenate was split into two samples and one sample was then centrifuged (16 g) further and the supernatant collected for analysis with Western blotting. The other sample was employed for iNOS gene analysis with total mRNA extracted using a commercial kit (Sigma).
Statistical analyses
One-way ANOVA analyses with the Newman-Keuls post-hoc test were performed to determine significant changes between data sets. In all cases, statistical significance was accepted at the 95 % confidence interval (P < 0.05).
RESULTS
Intracellular fluorescence increased in a dose-dependent manner in DAF-FM-loaded rat VSMCs following addition of 0.1, 1 or 10 μM ᭹ NO (derived from DeaNO) ( Figure 1A ), but did not lead to any significant increase in cell death over the 24 h period studied ( Figures 1B and 1C ): a marginal increase in Trypan Blue uptake was detected, although this did not reach statistical significance (P = 0.06; n = 6 samples). Together, these data suggest that the added ᭹ NO was capable of penetrating the cell membrane, but did not significantly affect cell viability.
To determine whether ᭹ NO was capable of altering the intracellular content of Mb, Mb gene expression was determined in cultured rat VSMCs exposed to vehicle (control), DeaNO or spermineNONOate as chemical sources of ᭹ NO (Figure 2 ). Irrespective of the donor, the gene encoding for Mb increased markedly 2 h after exposure to the ᭹ NO-donor, was sustained at 5 h and thereafter returned to basal levels 24 h after stimulation relative to the housekeeping gene (Figures 2A-2C) . Notably, VSMCs treated with diethylamine (at a final concentration corresponding to the highest concentration of DeaNO employed) showed no change in Mb gene expression ( Figure 2B ᭹ NO yet largely maintain cell membrane integrity and viability (A) Rat aortic VSMCs were pre-treated with the ᭹ NO-probe DAF-FM, prior to exposure to the chemical ᭹ NO donor DeaNO (at final ᭹ NO concentrations of 0.1, 1 or 10 μM) and fluorescence was visualized by confocal microscopy, as detailed in the Experimental section. (B) Rat aortic VSMCs were exposed to 10 μM DeaNO for 60 min, followed by re-culture in complete media, harvested at the times indicated, and cell membrane integrity was assessed with Trypan Blue exclusion as detailed in the Experimental section. The proportion of Trypan Blue-positive cells was determined to be 5.1 + − 3.6 % of the total cell population in the zero time. Results are expressed as the means + − S.E.M. fold-increase over control, derived from n = 6 independent cell treatments. (C) Rat aortic VSMCs, exposed to 10 μM DeaNO for 60 min, followed by re-culture in complete media for 24 h, were assessed for the extent of apoptosis (open bar) and necrosis (filled bar) using a combined approach of Annexin-FITC and PI dual staining and flow cytometry, as detailed in the Experimental section. Results represent means + − S.D. of the percentage cell population, derived from n = 2 independent experiments each performed in triplicate.
Mb commencing as early as 5 h post-treatment with the ᭹ NO donor and was sustained at increased levels over the 24 h assay period ( Figure 3A) . Similarly, fluorescent imaging of VSMCs treated with 10 μM DeaNO demonstrated an increase in immunoactive Mb present in the cell cytoplasm relative to cells exposed to the vehicle (control) when measured 24 h after treatment ( Figure 3B ). Parallel quantitative measurement of intracellular Mb fluorescence using flow cytometric analysis demonstrated a significant increase in the population of cells containing Mb when measured 24 h post-exposure to 10 μM DeaNO ( Figure 4C) .
Each Mb molecule contains a single haem prosthetic group that is crucial for binding molecular O 2 , and is directly involved in at least two pathways of Mb regulation of ᭹ NO (see the Introduction). Accumulation of Mb within VSMCs can be derived from a haem-containing protein (holo-Mb) or simply a Mb apo- protein (devoid of haem), both of which remain immunoreactive to antibodies raised against the Mb protein and therefore cannot be distinguished by immunoassays such as those shown in Figure 3 . To assess whether holo-Mb accumulated in the ᭹ NO-treated cells, we fractionated lysates of pooled rat VSMCs using reversedphase HPLC 24 h after exposure to ᭹ NO ( Figures 4A and 4B ). Fractions eluting from the column between 19-21 min contained Mb as a shoulder peak ( Figure 4B , arrow) as confirmed by comparing the retention time against a sample of horse heart Mb (results not shown). The presence of Mb in this fraction was confirmed by Western blotting where pooled samples of eluting Mb from VSMCs showed immunoreactivity similar to a standard of authentic horse heart Mb ( Figure 4C) . Importantly, the rate of ABTS oxidation increased significantly when exposed to a sample of the Mb fraction isolated from rat VSMCs relative to the control in the absence of ᭹ NO-treatment ( Figure 4D ). As anticipated, pre-incubation of Mb fractions isolated by chromatography with sodium cyanide significantly inhibited ABTS oxidation. Taken together, the enhanced oxidation of ABTS and its inhibition by cyanide is indicative that haem is incorporated into the protein, and that holo-Mb has accumulated in VSMCs following treatment with ᭹ NO. Next, we assessed whether ᭹ NO elicited an increase in Mb protein within intact rat aortic tissues incubated in the presence of L-arginine. Initially, the media content of nitrate/nitrite was negligible ( Figure 5A , complete arrow indicating addition of the sample). As anticipated, studies with addition of sodium nitrite (serving as a positive control, broken arrow) elicited a marked increase in the current response ( Figure 5A , broken arrow). Next, media samples from the isolated aortic segments incubated for 2, 5 and 7 days were tested and shown to yield increased ᭹ NO accumulation in the presence of L-arginine, as judged by the time-dependent increase in nitrate/nitrite measured with a ᭹ NO-electrode ( Figures 5B-5D , complete arrow). Notably, nitrate/nitrite increased to 10-15 pmol after 5 days of culture and remained constant thereafter, indicative of a time-dependent increase in the production of ᭹ NO in these tissue segments ( Figure 5E ). Together, these results indicated that isolated rat aortic vessels produced significant levels of ᭹ NO during culture for up to 1 week.
To explore a potential source of ᭹ NO in the aortic segments we assessed the tissue expression of the iNOS gene. Results shown in Figure 6 (A) indicate that expression of the gene encoding for iNOS showed a trend for increased expression when Rat aortic VSMCs were exposed to the chemical ᭹ NO donor DeaNO (final ᭹ NO concentration 10 μM), re-cultured in complete media, harvested after 24 h, and cytosolic Mb was isolated with HPLC using a C 4 column and gradient elution as detailed in the Experimental section. Chromatograms shown are representative of (A) lysis buffer alone or (B) pooled cell lysate with Mb eluting as a shoulder peak between 19-21 min (as indicated by the arrow). This shoulder peak corresponded to the retention time for authentic horse heart Mb (results not shown). Fractions containing Mb were collected and the presence of Mb was verified with a combined approach of SDS/PAGE and Western blotting (C). Lane 1: authentic horse heart Mb; lane 2: pooled fractions eluted from the lysate of VSMCs after exposure to ᭹ NO. (D) Mb-containing fractions were then mixed with 100 μM H 2 O 2 and 1 mM ABTS and the rate of ABTS radical formation was monitored with a UV-Vis spectrometer at 420 nm over 30 min. In some samples, cyanide anion was added to inhibit Mb peroxidase activity and thereby confirm haem incorporation into the Mb apoprotein. Results represent means + − S.D., n = 3 independent experiments. *Significantly different to the rate of ABTS oxidation obtained with Mb isolated from the control samples; P < 0.05; #Significantly less than Mb samples isolated from VSMCs exposed to ᭹ NO; P < 0.05. measured at days 1 and 3 compared with basal levels in the vessel, suggesting that iNOS may be responsible for the increased accumulation of ᭹ NO oxidation products in the media. Finally, we determined whether the cultured aortic segments contained elevated aortic content of Mb in response to increased production of ᭹ NO. Consistent with the cell culture studies, incubation of aortic segments with L-arginine over 3-5 days significantly increased total aortic Mb as judged by Western blots from samples of vascular homogenate ( Figure 6B) . Notably, repeated immunoprecipitation of the same sample resulted in no positive Mb bands in Western blots, indicating that the majority of the protein was efficiently removed in the first immunoprecipitation process (results not shown).
Figure 5
᭹ NO production increases in isolated rat aortic segments incubated in culture media supplemented with L-arginine Freshly isolated rat aortae were cut into 5 mm sections, ten sections were pooled into separate wells of a six-well plate and the tissue was covered with media containing 100 μM L-arginine, and incubated at 37 • C under 5 % CO 2 . Samples of media were taken daily over 7 days and immediately frozen and stored at − 80 • C. For analysis, culture media was thawed and treated with nitrate reductase in the presence of the necessary cofactors to convert nitrates into nitrite as described in the Experimental section. An aliquot of the mixture was transferred to an ᭹ NO-electrode pre-equilibrated in 0.1 M H 2 SO 4 and containing the iodide anion. The real-time current response was then monitored until a plateau was observed. Results represent samples from media obtained at (A) day 0, (B) day 2, (C) day 5 and (D) day 7, with the filled arrow indicating introduction of the sample. The broken arrow in (A) indicates addition of authentic sodium nitrite (∼ 200 nM) (positive control). (D) Peak response of the ᭹ NO electrode was integrated using the standard DUO-18 TM software (World Precision Instruments, v1.55) and quantified by peak area in comparison with a standard curve generated with authentic sodium nitrite. Results represent means + − S.D.; n = 4 experiments each performed in triplicate. *Significantly different to samples obtained at day 0; P < 0.05. In the absence of nitrate reductase, fresh media generated a weak signal corresponding to < 2 pmol of ᭹ NO/mg of protein.
DISCUSSION
The synthesis of vasoactive ᭹ NO is the first step in a cascade of events that leads to endothelium-dependent vessel dilation through activation of sGC to produce the intracellular effector molecule cGMP in vascular smooth muscle. Regulation of ᭹ NO bioavailability affects vascular tone and, therefore, mechanisms have evolved to tightly regulate the concentration of this potent cell signalling molecule in the vasculature and peripheral tissues [25] . In the present study we have identified a biochemical feedback mechanism that involves interplay between ᭹ NO and Mb in VSMCs underlying the vascular endothelium. Although ᭹ NO regulation in the vasculature is largely credited to the relatively high concentrations of haemoglobin (4-5 mM depending on Freshly isolated rat aortae were cut into 5 mm sections, pooled and incubated in culture media supplemented with L-arginine (100 μM), as described in the Experimental section. Aortic sections comprising the control (day 0, n = 4 pooled rings) or samples incubated for up to 7 days (n = 6 pooled samples). The rings were taken and homogenized and then split into two samples. (A) The first sample was then used to isolate total mRNA, the mRNA converted into cDNA and probed for the expression of the iNOS gene using S29 ribosomal protein RNA as the house-keeping control. Results represent means + − S.E.M., n = 3 pooled aortic ring samples. (B) The second sample of homogenate was normalized for total protein content and any cytosolic Mb immunoprecipitated, then separated by SDS/PAGE and visualized by Western blotting as described in the Experimental section. Results represent means + − S.D. with n values as indicated above. The representative Western blot (insert) shows two independent control samples (lanes 1 and 2) and two independent samples from day 7 (lanes 3 and 4) . the site within the circulatory tree [26] ), the role for Mb in regulating vascular ᭹ NO levels within the vessel wall has not been previously established. Results obtained in the present study with cultured VSMCs and isolated aortic segments have demonstrated that pathological concentrations of ᭹ NO can stimulate an increase in Mb gene expression with resultant accumulation of the holo-protein in the cell cytoplasm. This may result in the enhanced elimination of ᭹ NO in the vessel wall and effectively protect mitochondria within VSMCs from ᭹ NO poisoning through limiting the available ᭹ NO for binding of mitochondrial haemoproteins during an inflammatory process. One caveat to this ability for ᭹ NO to stimulate expression of Mb is that Mb itself exhibits nitrite reductase activity and generates ᭹ NO under anaerobic conditions that mimic ischaemic injury [27] . In contrast, under aerobic conditions, Mb oxidizes ᭹ NO into higher oxidation states such as nitrite or nitrate [10] . Therefore it is possible that Mb can be involved in a self-regulating loop process that involves evolution of ᭹ NO in tissues exposed to low-oxygen tension ( [28] , [29] , but see [29a] ), whereas under normoxic conditions changes in Mb content within VSMCs are not required.
Parallels between the interactions between haemoglobin/ ᭹ NO and Mb/ ᭹ NO are readily drawn on to explain how ᭹ NO concentrations are regulated in vivo and under different pathological conditions, albeit these proteins exist largely in separate biological compartments. Within cardiac and skeletal muscle, Mb is one of the more prevalent cellular proteins, with concentrations ranging from 0.1 to 0.4 mM, and its primary role in facilitating oxygen transport is well established [6] . In addition to oxygen transport, a number of research groups have contributed to extending our understanding of the role for Mb in regulating nitrosative stress. Thus increased expression of iNOS in the myocardium is implicated in decreased consumption of molecular oxygen [30] , impaired myocyte contractility and bioenergetics [31] and increased cardiac myocyte apoptosis [32] . This body of evidence taken together with a study that indicates an insufficiency in the translational diffusion of cardiac Mb to fully account for oxygen transport in myocytes under normal oxygen tension [33] supports the conclusion that Mb probably plays several roles in heart muscle. Thus, in addition to facilitating oxygen transport and acting as a storage reservoir for dioxygen, Mb also plays a role in scavenging ᭹ NO and thereby regulating its bioactivity and bioavailability [34] .
Although a role for Mb in scavenging ᭹ NO is now established in Mb-rich tissues such as the heart and skeletal muscle, a similar role for Mb within VSMCs underlying the vascular endothelium has not been previously revealed, despite the documented presence of Mb in smooth muscle [9] . Moreover, the ability for ᭹ NO to elicit Mb gene and protein expression in VSMCs underpins the tight relationship between these two components of the vasculature. For example, mice deficient in Mb exhibit multiple compensatory mechanisms that increase capillary density and enhance oxygen diffusion into major organs such as the heart [35] . Furthermore, Mb overexpression can impair angiogenesis in an animal model of hind-leg ischaemia [36] . Nitric oxide and the molecular pathways regulated by this potent signalling molecule play an integral role in the development and maintenance of microvascular networks in various tissues [37, 38] . Therefore results from these animal studies can be taken as strong support for the idea that Mb regulates ᭹ NO concentrations in vivo. The molecular mechanism for ᭹ NO regulation of Mb gene and protein expression in VSMCs detected in the present study is not clear. Stimulation of Mb gene expression occurs during myogenesis through the transient expression of MNF [39] . Increased Mb gene expression has also been documented in skeletal muscle during endurance training under hypoxic conditions [40] . Multiple transcriptional control elements have been identified for muscle-specific expression of the human Mb gene [41, 42] , with a CCAC box sequence and a MEF2 (myocyte enhancer factor-2)-like consensus sequence linked to protein transcription by the native Mb promoter. In addition, overexpression of vascular endothelial growth factor in skeletal muscle prior to experimental ischaemia elicits Mb gene expression [43] , and the Mb protein concentration in skeletal muscle shows some dependency on the bioavailability of iron [44] . Whether the transcriptional elements that control Mb gene expression are affected directly by ᭹ NO is not presently known, and we were unable to detect MNF expression in VSMCs exposed to ᭹ NO at any time. Further studies are warranted to identify the molecular mechanism that explains ᭹ NO-mediated increases in Mb concentration within VSMCs.
The ability of ᭹ NO to reversibly inhibit respiration by binding to both haem iron (competitively) and copper (non-competitively) centres in cytochrome c oxidase [45] has been suggested as a mechanism that regulates mitochondrial function and in turn the cellular pool of ATP. On this basis, the simplest interpretation for the ability of VSMCs to enhance ᭹ NO clearance by increasing their cytosolic content of Mb appears to be a protective biochemical feedback mechanism that acts to maintain mitochondrial respiration at times of increased nitrosative stress. However, interactions between cytochrome c oxidase and ᭹ NO are complicated by changes in activity induced by ᭹ NO that are not simply limited to complete inhibition of electron transport (referred to as ᭹ NO poisoning). Thus it is known that ᭹ NO can control cytochrome c oxidase activity [46] , and this may be dependent on the local cellular concentration of dioxygen and the flux of electrons flowing through the respiratory chain. Thus during periods of normal mitochondrial function, oxidation of ᭹ NO by cytochrome c oxidase may inhibit electron flow and inhibit ATP production. On the other hand, inhibition of cytochrome c oxidase is also important in limiting the excessive buildup of mitochondrial membrane potential that in turn promotes the generation of reactive oxygen species under pathological conditions [47] . This form of mitochondrial dysfunction may involve S-nitrosylation of proteins that comprise mitochondrial complex 1 through interactions with low-molecular-mass S-nitrosothiols [48] . Therefore the precise level of cellular ᭹ NO needs to be carefully regulated so as to maintain ᭹ NO-dependent control of mitochondrial electron transport. In view of this, the expression of Mb in VSMCs exposed to ᭹ NO may be seen as an additional level of regulation that is involved in strictly maintaining ᭹ NO homoeostasis and therefore the balance of intracellular nitrosative stress.
The pathophysiological relevance of the present study depends on the likelihood that VSMCs are being exposed to the ᭹ NO concentrations used here. Under normal physiological conditions, ᭹ NO concentrations range up to a maximum of 1 μM at any given time in the vasculature tree (for a review, see [49] ). However, as ᭹ NO is generated in a paracrine fashion to act locally at sites within the vessel wall, local ᭹ NO concentrations are estimated to be significantly lower, ∼ 0.01 nM [50] . Importantly, ᭹ NO concentrations increase significantly in severe cases of inflammation, such as that measured in animal models of allograft rejection [51] and sepsis in humans [52, 53] ; reportedly ᭹ NO can achieve up to ∼ 10 μM concentration in the vasculature as measured directly using a ᭹ NO-sensitive electrode. In addition, ᭹ NO is freely diffusible, and it is therefore plausible that VSMCs are exposed (locally) to relatively high micromolar concentrations of ᭹ NO in the setting of severe inflammation. Under these conditions, ᭹ NO-mediated increases in Mb gene and protein expression is feasible.
In summary, we have demonstrated that VSMCs respond to nitrosative stress by induction of the Mb gene and a parallel increase in holo-Mb accumulation in the cytoplasm of these cells. This regulation occurs in cultured VSMCs and, importantly, is recapitulated within isolated aortic vessels. This relationship between ᭹ NO and Mb may represent a novel biochemical feedback loop that regulates the concentration of ᭹ NO in the vessel wall and may ultimately protect VSMC mitochondria from ᭹ NO-induced stress and damage.
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